What’s in a biotech name? How drug startups choose their brand
Elie Dolgin • March 9, 2016
The intellectual property is secure. The science is sound. You’re about to make your pitch for funding. The scary next step for a biotech entrepreneur? Picking a company name.
Continue reading at STAT.
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.